Efficacy of Nirmatrelvir-Ritonavir versus Azvudine for COVID-19 Treatment in Tibet: A Retrospective Study.

Xiang Zhao,Yuan Cheng,Meng Zhang,Bianba Qianda,Baima Zhouma,Bianba Yangzhen, Yao Zheng,Shuo Zhang,Huiying Zhao

Infection and drug resistance（2023）

引用 0|浏览5

暂无评分

摘要

Azvudine is generally as effective as nirmatrelvir-ritonavir, but for patients with mild COVID-19, nirmatrelvir-ritonavir could suppress the virus more rapidly. For those who cannot be treated with nirmatrelvir-ritonavir, azvudine might be an effective therapy for COVID-19.

查看译文

关键词

azvudine,tibet,nirmatrelvir-ritonavir

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要